Effects of Enzyme Replacement Therapy and Antidrug Antibodies in Patients with Fabry Disease.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of the American Society of Nephrology : JASN"
DOI: 10.1681/asn.2018030329
Abstract: Fabry disease (FD) is an X-linked lysosomal storage disorder (LSD) caused by mutations of the α-galactosidase A gene. The lysosomal enzyme α -galactosidase A (GLA) mediates the hydrolysis of the terminal α -galactosyl moiety from… read more here.
Keywords: replacement therapy; therapy antidrug; effects enzyme; enzyme replacement ... See more keywords